These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

240 related items for PubMed ID: 18337474

  • 1. Interleukin-13 neutralization by two distinct receptor blocking mechanisms reduces immunoglobulin E responses and lung inflammation in cynomolgus monkeys.
    Kasaian MT, Tan XY, Jin M, Fitz L, Marquette K, Wood N, Cook TA, Lee J, Widom A, Agostinelli R, Bree A, Schlerman FJ, Olland S, Wadanoli M, Sypek J, Gill D, Goldman SJ, Tchistiakova L.
    J Pharmacol Exp Ther; 2008 Jun; 325(3):882-92. PubMed ID: 18337474
    [Abstract] [Full Text] [Related]

  • 2. IL-13 blockade reduces lung inflammation after Ascaris suum challenge in cynomolgus monkeys.
    Bree A, Schlerman FJ, Wadanoli M, Tchistiakova L, Marquette K, Tan XY, Jacobson BA, Widom A, Cook TA, Wood N, Vunnum S, Krykbaev R, Xu X, Donaldson DD, Goldman SJ, Sypek J, Kasaian MT.
    J Allergy Clin Immunol; 2007 May; 119(5):1251-7. PubMed ID: 17379289
    [Abstract] [Full Text] [Related]

  • 3. Preclinical safety and pharmacology of an anti-human interleukin-13 monoclonal antibody in normal macaques and in macaques with allergic asthma.
    Martin PL, Fisher D, Glass W, O'Neil K, Das A, Martin EC, Li L.
    Int J Toxicol; 2008 May; 27(5):351-8. PubMed ID: 19037805
    [Abstract] [Full Text] [Related]

  • 4. Preclinical efficacy and safety of mepolizumab (SB-240563), a humanized monoclonal antibody to IL-5, in cynomolgus monkeys.
    Hart TK, Cook RM, Zia-Amirhosseini P, Minthorn E, Sellers TS, Maleeff BE, Eustis S, Schwartz LW, Tsui P, Appelbaum ER, Martin EC, Bugelski PJ, Herzyk DJ.
    J Allergy Clin Immunol; 2001 Aug; 108(2):250-7. PubMed ID: 11496242
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Novel recombinant interleukin-13 peptide-based vaccine reduces airway allergic inflammatory responses in mice.
    Ma Y, HayGlass KT, Becker AB, Fan Y, Yang X, Basu S, Srinivasan G, Simons FE, Halayko AJ, Peng Z.
    Am J Respir Crit Care Med; 2007 Sep 01; 176(5):439-45. PubMed ID: 17556715
    [Abstract] [Full Text] [Related]

  • 7. Blockade of interleukin-13-mediated cell activation by a novel inhibitory antibody to human IL-13 receptor alpha1.
    Krause S, Behrends J, Borowski A, Lohrmann J, Lang S, Myrtek D, Lorenzen T, Virchow JC, Luttmann W, Friedrich K.
    Mol Immunol; 2006 Apr 01; 43(11):1799-807. PubMed ID: 16364441
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Chemokine receptor 2 blockade prevents asthma in a cynomolgus monkey model.
    Mellado M, Martín de Ana A, Gómez L, Martínez C, Rodríguez-Frade JM.
    J Pharmacol Exp Ther; 2008 Feb 01; 324(2):769-75. PubMed ID: 18029547
    [Abstract] [Full Text] [Related]

  • 12. Induction of IgE-mediated cutaneous, cellular, and airway reactivity in rhesus monkeys by Ascaris suum infection.
    Patterson R, Harris KE, Pruzansky JJ.
    J Lab Clin Med; 1983 Jun 01; 101(6):864-72. PubMed ID: 6189928
    [Abstract] [Full Text] [Related]

  • 13. Potent neutralizing anti-CD1d antibody reduces lung cytokine release in primate asthma model.
    Nambiar J, Clarke AW, Shim D, Mabon D, Tian C, Windloch K, Buhmann C, Corazon B, Lindgren M, Pollard M, Domagala T, Poulton L, Doyle AG.
    MAbs; 2015 Jun 01; 7(3):638-50. PubMed ID: 25751125
    [Abstract] [Full Text] [Related]

  • 14. Evaluation of the effect of a platelet activating factor antagonist on platelet activating factor and Ascaris antigen-induced airway responses in rhesus monkeys.
    Patterson R, Harris KE, Handley DA, Saunders RN.
    J Lab Clin Med; 1987 Nov 01; 110(5):606-11. PubMed ID: 3668360
    [Abstract] [Full Text] [Related]

  • 15. Echinococcus multilocularis metacestode extract triggers human basophils to release interleukin-4.
    Aumüller E, Schramm G, Gronow A, Brehm K, Gibbs BF, Doenhoff MJ, Haas H.
    Parasite Immunol; 2004 Oct 01; 26(10):387-95. PubMed ID: 15752116
    [Abstract] [Full Text] [Related]

  • 16. Molecular cloning of the swine IL-4 receptor alpha and IL-13 receptor 1-chains: effects of experimental Toxoplasma gondii, Ascaris suum and Trichuris suis infections on tissue mRNA levels.
    Zarlenga DS, Dawson H, Kringel H, Solano-Aguilar G, Urban JF.
    Vet Immunol Immunopathol; 2004 Oct 01; 101(3-4):223-34. PubMed ID: 15350752
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. PAS-1, a protein from Ascaris suum, modulates allergic inflammation via IL-10 and IFN-gamma, but not IL-12.
    Araújo CA, Perini A, Martins MA, Macedo MS, Macedo-Soares MF.
    Cytokine; 2008 Dec 01; 44(3):335-41. PubMed ID: 19008120
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Parallel induction of IgE-mediated Ascaris antigen airway responses and increased carbachol airway reactivity in rhesus monkeys by infection with Ascaris suum.
    Patterson R, Harris KE.
    J Lab Clin Med; 1985 Sep 01; 106(3):293-7. PubMed ID: 4031630
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.